about
The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004Effectiveness of influenza vaccination for preventing influenza-related complications in people with asthma: a systematic review protocolEarly estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE): use of a unique community and laboratory national data-linked cohort study.Major incidents in rural areas: managing a pandemic A/H1N1/2009 cluster.Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) diseaseUse of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United KingdomOseltamivir-resistant pandemic (H1N1) 2009 virus infection in England and Scotland, 2009-2010.Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approachEffectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study.Fatal cases of influenza a in childhood.Seasonal Influenza Vaccine Effectiveness in the community (SIVE): protocol for a cohort study exploiting a unique national linked data set.Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in ScotlandDeath or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types.Differences between asthmatics and nonasthmatics hospitalised with influenza A infection.Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.Evaluating the effectiveness, impact and safety of live attenuated and seasonal inactivated influenza vaccination: protocol for the Seasonal Influenza Vaccination Effectiveness II (SIVE II) study.Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients.Effectiveness of influenza vaccines in asthma: a systematic review and meta-analysis.Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere.Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results.Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results.Increase in Legionnaires' disease cases associated with travel to Dubai among travellers from the United Kingdom, Sweden and the Netherlands, October 2016 to end August 2017.Veterinary public health.Antibiotic resistance in invasive Streptococcus pneumoniae isolates identified in Scotland between 1999 and 2007.Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis.Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level.Minimum dataset for confirmed human cases of influenza H5N1.Pandemic influenza vaccination for healthcare workers in primary care: good progress, but higher uptake required.End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.Risk factors for admission to hospital with laboratory-confirmed influenza in young children: birth cohort study.Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season.Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland.Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies.Moving epidemic method (MEM) applied to virology data as a novel real time tool to predict peak in seasonal influenza healthcare utilisation. The Scottish experience of the 2017/18 season to date.Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17Modelling the population effectiveness of the national seasonal influenza vaccination programme in Scotland: the impact of targeting all individuals aged 65 years and over Flu Vaccination Programme EffectivenessThe contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK
P50
Q21261529-4E2ECC5F-4D58-4066-83A6-FE129619BB0CQ28077038-E79649C0-46A6-4DEE-A403-A9CD2A5468CBQ30380098-9A7DD9AC-0109-4686-8722-244E5C3A7F44Q30392521-E4111C5D-D379-4010-88DD-233740870945Q30398779-1B187AD3-2AB0-4C48-BA55-BAC98BDD75A5Q30402302-FDFD0EE9-AEEF-4379-86D4-45EEA0796A57Q30404708-5219AB18-DF99-4685-BC9C-9DBCB3A8D70EQ30408174-F4EE873E-B3D3-4FD7-A62B-1EC7028DB895Q30411303-B2379DCA-7F8B-4DFE-8D61-1CB2B0E70FE6Q30418619-BBAA559A-68DD-4C98-8F7B-A978D22D53E5Q33513974-33C8C558-1B68-4414-AD8F-FB4B525A9633Q34197731-A5DC81A8-C9C9-4B9B-8382-3746D204BC88Q34569142-224EAB26-184A-47F0-903B-8FA76E27065AQ35199208-10EC6A4E-C1FE-4BD0-A379-D09053C6249CQ36729465-1311C078-86B0-4C87-A156-3AB8C884C2D0Q37355265-6A2EC327-D1FF-4957-8934-6F1E155B8EE9Q37681302-CDAB5F7D-1FEB-4765-ACB3-0BF9E9A9EFB6Q39121772-AEE92A2F-ABDC-495E-AD4E-B754F86FE35DQ39358078-9C9A7F4A-8402-4BF3-8269-7F610E34D09FQ40074131-E0A95D4D-EF00-49AA-BAE0-207C6C8349C3Q40357312-F66F5FD9-F146-4DD9-8E2F-2AC3E504F6B4Q40802753-C5FEC841-E8A2-4FEA-9179-85A56703EFF5Q41932632-EBAC23B1-DD1C-4A64-A0EE-17DD12E9E191Q42590843-ED0F9AAB-3D40-4297-99DD-2DBA9B04C56DQ42962031-35E42CFB-8D1D-4D42-9C86-38AAFF15CA0BQ42982505-DCA12900-7E54-4671-84A0-320A0D8997ABQ44464311-2692AC66-3908-4519-890F-D8241E5F27F6Q44693872-BD217221-07E5-4D9A-B790-4021F375DBABQ46732615-2C108B0F-3BD4-448A-A794-EA5179FC8B9AQ47154049-409787C7-D18A-4F5F-9364-5EF3D78E7B39Q47910350-78437479-4DEC-4567-9E4F-BBB8BA0ECB78Q51174772-D4E2B0DA-116B-4985-8099-5DF91AE55F38Q51193840-03310092-02EE-4498-9AEB-427FBA8E1892Q52644134-1E142874-082F-457D-BAA4-C410A8E5AE94Q54261205-7F2FA0D2-4ED5-4FC0-8D43-623C2BFC475DQ55234477-14D06DFE-6817-4E2F-A43C-7CA61D6D75F5Q57122379-A3AEF709-9843-4D99-B1FE-345219472183Q59358635-4975F886-37F4-4A66-B548-7E831386F8E4Q61451414-71071AAA-AA52-41CC-9265-E4CD8245402EQ63859514-0AA1F44B-099D-49A2-BF5B-E2E067EC7839
P50
name
Jim McMenamin
@en
Jim McMenamin
@nl
type
label
Jim McMenamin
@en
Jim McMenamin
@nl
prefLabel
Jim McMenamin
@en
Jim McMenamin
@nl